Granted Patent
B2
US 7,465,572 · App. 11/516,295 · Granted Dec 16, 2008
De-immunized streptokinase
Assignee:
Merck Patent GmbH
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A target protein is rendered less immunogenic to a given species by (a) determining at least part of the amino acid sequence of the target protein; (b) identifying in the amino acid sequence one or more potential epitopes for T-cells (“T-cell epitopes”) of the given species; and (c) modifying the amino acid sequence to eliminate at least one of the T-cell epitopes identified in step (b) to reduce the immunogenicity of the protein when exposed to the immune system of the given species.
Claims (2)
1. An isolated protein comprising a modified streptokinase having the amino acid sequence set forth in SEQ ID NO: 253.
2. A pharmaceutical composition comprising an isolated protein of claim 1 in a pharmaceutically acceptable carrier.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 14, 2007
From: BIOVATION LIMITED
To: MERCK PATENT GMBH
Reel/Frame 020259/0526 →
Priority Claims (4)
GB 9710480.6
· May 21, 1997
· national
GB 9716197.0
· Jul 31, 1997
· national
GB 9725270.4
· Nov 28, 1997
· national
GB 9807751.4
· Apr 14, 1998
· national
Continuity (5)
Continuation
PCTGB980147300
· May 21, 1998
Provisional Application
6006723500
· Dec 2, 1997